In March this year, a very important meeting took place in Brussels, Belgium – IMI (Innovative Medicines Initiative) invited its projects working on Alzheimer’s disease to present their goals and preliminary results, and to discuss potential synergies that would help go beyond what is currently being done. 

AMYPAD was one of the invited projects and Frederik Barkhof together with Gill Farrar presented the AMYPAD Project, the consortium, the project objectives, its structure and its collaboration with other IMI as well as external projects.